The neuroprotective effect of Activin A and B: Implication for neurodegenerative diseases

Journal of Neurochemistry

Volumn 103, Issue 3, 2007, Pages 962-971

  Kupershmidt, Lana ^a   Amit, Tamar ^a   Bar Am, Orit ^a   Youdim, Moussa B H ^a   Blumenfeld, Zeev ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Activin; Bcl 2 family; Neurodegenerative diseases; Neuronal apoptosis; Neuroprotection

Indexed keywords

ACTIVIN A; CASPASE 3; LINSIDOMINE; MYELOPID; NEUROTOXIN; OXIDOPAMINE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BCL 2; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; PARKINSONISM; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TRANSIENT TRANSFECTION;

ACTIVINS; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BRAIN; CELL LINE, TUMOR; CELL SURVIVAL; CULTURE MEDIA, SERUM-FREE; HISTONES; HUMANS; MOLSIDOMINE; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXIDOPAMINE; PC12 CELLS; POLY(ADP-RIBOSE) POLYMERASES; RATS; TRANSFECTION; TYROSINE 3-MONOOXYGENASE;

RATTUS;

EID: 35248897112     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04785.x     Document Type: Article

References (46)

1. Adams J. M. Cory S. (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322 1326.
2. Andoh T., Chock P. B. Chiueh C. C. (2002) Preconditioning-mediated neuroprotection: role of nitric oxide, cGMP, and new protein expression. Ann. N Y Acad Sci. 962, 1 7.
3. Atabay C., Cagnoli C. M., Kharlamov E., Ikonomovic M. D. Manev H. (1996) Removal of serum from primary cultures of cerebellar granule neurons induces oxidative stress and DNA fragmentation: protection with antioxidants and glutamate receptor antagonists. J. Neurosci. Res. 43, 465 475.
4. Avramovich-Tirosh Y., Amit T., Bar-Am O., Zheng H., Fridkin M. Youdim M. B. (2007) Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhbitor drug, M-30, for the treatment of Alzheimer's disease. J. Neurochem. 100, 490 502.
5. Ba F., Pang P. K. Benishin C. G. (2003) The establishment of a reliable cytotoxic system with SK-N-SH neuroblastoma cell culture. J. Neurosci. Methods 123, 11 22.
6. Bao Y. L., Tsuchida K., Liu B., Kurisaki A., Matsuzaki T. Sugino H. (2005) Synergistic activity of activin A and basic fibroblast growth factor on tyrosine hydroxylase expression through Smad3 and ERK1/ERK2 MAPK signaling pathways. J. Endocrinol. 184, 493 504.
7. Bar-Am O., Weinreb O., Amit T. Youdim M. B. (2005) Regulation of Bcl-2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine. FASEB J. 19, 1899 1901.
8. Cameron V. A., Nishimura E., Mathews L. S., Lewis K. A., Sawchenko P. E. Vale W. W. (1994) Hybridization histochemical localization of activin receptor subtypes in rat brain, pituitary, ovary, and testis. Endocrinology 134, 799 808.
9. Cory S. Adams J. M. (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2, 647 656.
10. Decker P. Muller S. (2002) Modulating poly (ADP-ribose) polymerase activity: potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress. Curr. Pharm. Biotechnol. 3, 275 283.
11. Dow A. L., Russell D. S. Duman R. S. (2005) Regulation of activin mRNA and Smad2 phosphorylation by antidepressant treatment in the rat brain: effects in behavioral models. J. Neurosci. 25, 4908 4916.
12. Evan G. Littlewood T. (1998) A matter of life and cell death. Science 281, 1317 1322.
13. Fann M. J. Patterson P. H. (1994) Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured sympathetic neurons. Proc. Natl Acad. Sci. USA 91, 43 47.
14. Foster J. A., Puchowicz M. J., McIntyre D. C. Herkenham M. (2004) Activin mRNA induced during amygdala kindling shows a spatiotemporal progression that tracks the spread of seizures. J. Comp. Neurol. 476, 91 102.
15. Gomez-Santos C., Ambrosio S., Ventura F., Ferrer I. Reiriz J. (2002) TGF-beta1 increases tyrosine hydroxylase expression by a mechanism blocked by BMP-2 in human neuroblastoma SH-SY5Y cells. Brain Res. 958, 152 160.
16. Hughes P. E., Alexi T., Williams C. E., Clark R. G. Gluckman P. D. (1999) Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease. Neuroscience 92, 197 209.
17. Iwahori Y., Saito H., Torii K. Nishiyama N. (1997) Activin exerts a neurotrophic effect on cultured hippocampal neurons. Brain Res. 760, 52 58.
18. Jellinger K. A. (2000) Cell death mechanisms in Parkinson's disease. J. Neural Transm. 107, 1 29.
19. Krieglstein K., Suter-Crazzolara C., Fischer W. H. Unsicker K. (1995) TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J. 14, 736 742.
20. Lai M., Sirimanne E., Williams C. E. Gluckman P. D. (1996) Sequential patterns of inhibin subunit gene expression following hypoxic-ischemic injury in the rat brain. Neuroscience 70, 1013 1024.
21. Levites Y., Amit T., Youdim M. B. Mandel S. (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J. Biol. Chem. 277, 30574 30580.
22. Macleod M. R., Allsopp T. E., McLuckie J. Kelly J. S. (2001) Serum withdrawal causes apoptosis in SHSY 5Y cells. Brain Res. 889, 308 315.
23. Maruyama W., Takahashi T., Youdim M. Naoi M. (2002) The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells. J. Neural Transm. 109, 467 481.
24. Michel U., Gerber J., E O'Connor A., Bunkowski S., Bruck W., Nau R. Phillips D. J. (2003) Increased activin levels in cerebrospinal fluid of rabbits with bacterial meningitis are associated with activation of microglia. J. Neurochem. 86, 238 245.
25. Mukerji S. S., Katsman E. A., Wilber C., Haner N. A., Selman W. R. Hall A. K. (2006) Activin is a neuronal survival factor that is rapidly increased after transient cerebral ischemia and hypoxia in mice. J. Cereb. Blood Flow Metab. in press.
26. Muller M. R., Zheng F., Werner S. Alzheimer C. (2006) Transgenic mice expressing dominant-negative activin receptor IB in forebrain neurons reveal novel functions of activin at glutamatergic synapses. J. Biol. Chem. 281, 29076 29084.
27. Munz B., Tretter Y. P., Hertel M., Engelhardt F., Alzheimer C. Werner S. (2001) The roles of activins in repair processes of the skin and the brain. Mol. Cell. Endocrinol. 180, 169 177.
28. Nagatsu T., Levitt M. Udenfriend S. (1964) Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J. Biol. Chem. 239, 2910 2917.
29. Oltvai Z. N., Milliman C. L. Korsmeyer S. J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609 619.
30. Pangas S. A. Woodruff T. K. (2000) Activin signal transduction pathways. Trends Endocrinol. Metab. 11, 309 314.
31. Paull T. T., Rogakou E. P., Yamazaki V., Kirchgessner C. U., Gellert M. Bonner W. M. (2000) A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10, 886 895.
32. Prehn J. H., Bindokas V. P., Marcuccilli C. J., Krajewski S., Reed J. C. Miller R. J. (1994) Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type beta confers wide-ranging protection on rat hippocampal neurons. Proc. Natl Acad. Sci. USA 91, 12599 12603.
33. Roberts V. J. Barth S. L. (1994) Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid- and late-gestation rat embryogenesis. Endocrinology 134, 914 923.
34. Russo V. C., Metaxas S., Kobayashi K., Harris M. Werther G. A. (2004) Antiapoptotic effects of leptin in human neuroblastoma cells. Endocrinology 145, 4103 4112.
35. Schubert D., Kimura H., LaCorbiere M., Vaughan J., Karr D. Fischer W. H. (1990) Activin is a nerve cell survival molecule. Nature 344, 868 870.
36. Sulyok S., Wankell M., Alzheimer C. Werner S. (2004) Activin: an important regulator of wound repair, fibrosis, and neuroprotection. Mol. Cell. Endocrinol. 225, 127 132.
37. Tretter Y. P., Munz B., Hubner G., ten Bruggencate G., Werner S. Alzheimer C. (1996) Strong induction of activin expression after hippocampal lesion. Neuroreport 7, 1819 1823.
38. Tretter Y. P., Hertel M., Munz B., ten Bruggencate G., Werner S. Alzheimer C. (2000) Induction of activin A is essential for the neuroprotective action of basic fibroblast growth factor in vivo. Nat. Med. 6, 812 815.
39. Wankell M., Werner S. Alzheimer C. (2003) The roles of activin in cytoprotection and tissue repair. Ann. N Y Acad Sci. 995, 48 58.
40. Weinreb O., Bar-Am O., Amit T., Chillag-Talmor O. Youdim M. B. (2004) Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members. FASEB J. 18, 1471 1473.
41. Werner S. Alzheimer C. (2006) Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev. 17, 157 171.
42. Wu D. D., Lai M., Hughes P. E., Sirimanne E., Gluckman P. D. Williams C. E. (1999) Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat. Brain Res. 835, 369 378.
43. Yuan J. Yankner B. A. (2000) Apoptosis in the nervous system. Nature 407, 802 809.
44. Zha J., Harada H., Yang E., Jockel J. Korsmeyer S. J. (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87, 619 628.
45. Zhang L., Himi T., Morita I. Murota S. (2000) Hepatocyte growth factor protects cultured rat cerebellar granule neurons from apoptosis via the phosphatidylinositol-3 kinase/Akt pathway. J. Neurosci. Res. 59, 489 496.
46. Zhu Y., Yang G. Y., Ahlemeyer B., Pang L., Che X. M., Culmsee C., Klumpp S. Krieglstein J. (2002) Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 22, 3898 3909.